NEFL and neuropathy: Using the Kruskal–Wallis test, we showed that NF-L concentrations, regardless of the stage of therapy, increased with the severity of neuropathy symptoms (CIPN G1 vs. CIPN G2 vs. CIPN G3) (Figure 6).